| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | GTPase activator activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 2.26e-10 | 279 | 55 | 11 | GO:0005096 |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D HERC1 TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 1.03e-08 | 507 | 55 | 12 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D HERC1 TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 1.03e-08 | 507 | 55 | 12 | GO:0030695 |
| GeneOntologyMolecularFunction | enzyme activator activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 1.42e-06 | 656 | 55 | 11 | GO:0008047 |
| GeneOntologyMolecularFunction | enzyme regulator activity | TBC1D3E GBP6 TBC1D3 TBC1D3H TBC1D3L TBC1D3D HERC1 TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 9.61e-05 | 1418 | 55 | 13 | GO:0030234 |
| GeneOntologyMolecularFunction | thiolester hydrolase activity | 2.94e-04 | 47 | 55 | 3 | GO:0016790 | |
| GeneOntologyMolecularFunction | molecular function activator activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 4.60e-04 | 1233 | 55 | 11 | GO:0140677 |
| GeneOntologyBiologicalProcess | activation of GTPase activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B CRKL TBC1D3K TBC1D3F | 5.67e-17 | 109 | 53 | 12 | GO:0090630 |
| GeneOntologyBiologicalProcess | positive regulation of GTPase activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B CRKL TBC1D3K TBC1D3F | 9.95e-13 | 244 | 53 | 12 | GO:0043547 |
| GeneOntologyBiologicalProcess | regulation of GTPase activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B CRKL TBC1D3K TBC1D3F | 4.07e-11 | 335 | 53 | 12 | GO:0043087 |
| GeneOntologyBiologicalProcess | positive regulation of hydrolase activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B CRKL TBC1D3K TBC1D3F | 3.82e-09 | 499 | 53 | 12 | GO:0051345 |
| GeneOntologyBiologicalProcess | regulation of hydrolase activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B CRKL TBC1D3K TBC1D3F | 1.75e-06 | 878 | 53 | 12 | GO:0051336 |
| GeneOntologyBiologicalProcess | positive regulation of catalytic activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B CRKL TBC1D3K TBC1D3F | 8.83e-06 | 1028 | 53 | 12 | GO:0043085 |
| GeneOntologyBiologicalProcess | parathyroid gland development | 1.80e-04 | 8 | 53 | 2 | GO:0060017 | |
| GeneOntologyBiologicalProcess | positive regulation of molecular function | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B CRKL TBC1D3K TBC1D3F | 2.19e-04 | 1430 | 53 | 12 | GO:0044093 |
| Domain | TBC | TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 1.04e-16 | 49 | 53 | 10 | SM00164 |
| Domain | RabGAP-TBC | TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 2.45e-16 | 53 | 53 | 10 | PF00566 |
| Domain | TBC_RABGAP | TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 3.65e-16 | 55 | 53 | 10 | PS50086 |
| Domain | Rab-GTPase-TBC_dom | TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 3.65e-16 | 55 | 53 | 10 | IPR000195 |
| Domain | HOTDOG_ACOT | 4.72e-05 | 4 | 53 | 2 | IPR033120 | |
| Domain | HOTDOG_ACOT | 4.72e-05 | 4 | 53 | 2 | PS51770 | |
| Domain | Thioestr_dom | 1.64e-04 | 7 | 53 | 2 | IPR006683 | |
| Domain | 4HBT | 1.64e-04 | 7 | 53 | 2 | PF03061 | |
| Domain | HotDog_dom | 3.50e-04 | 10 | 53 | 2 | IPR029069 | |
| Domain | - | 3.50e-04 | 10 | 53 | 2 | 3.10.129.10 | |
| Domain | START | 8.10e-04 | 15 | 53 | 2 | PF01852 | |
| Domain | START_lipid-bd_dom | 8.10e-04 | 15 | 53 | 2 | IPR002913 | |
| Domain | START | 8.10e-04 | 15 | 53 | 2 | PS50848 | |
| Domain | TF_T-box | 1.05e-03 | 17 | 53 | 2 | IPR001699 | |
| Domain | TBOX | 1.05e-03 | 17 | 53 | 2 | SM00425 | |
| Domain | TF_T-box_CS | 1.05e-03 | 17 | 53 | 2 | IPR018186 | |
| Domain | - | 1.05e-03 | 17 | 53 | 2 | 2.60.40.820 | |
| Domain | TBOX_3 | 1.05e-03 | 17 | 53 | 2 | PS50252 | |
| Domain | T-box | 1.05e-03 | 17 | 53 | 2 | PF00907 | |
| Domain | TBOX_1 | 1.05e-03 | 17 | 53 | 2 | PS01283 | |
| Domain | TBOX_2 | 1.05e-03 | 17 | 53 | 2 | PS01264 | |
| Domain | - | 1.92e-03 | 23 | 53 | 2 | 3.30.530.20 | |
| Domain | START-like_dom | 1.92e-03 | 23 | 53 | 2 | IPR023393 | |
| Domain | Homeodomain-like | 2.46e-03 | 332 | 53 | 5 | IPR009057 | |
| Domain | SANT_dom | 2.46e-03 | 26 | 53 | 2 | IPR017884 | |
| Domain | SANT | 2.85e-03 | 28 | 53 | 2 | PS51293 | |
| Domain | ZnMc | 3.05e-03 | 29 | 53 | 2 | SM00235 | |
| Domain | Peptidase_Metallo | 3.05e-03 | 29 | 53 | 2 | IPR006026 | |
| Domain | Myb_DNA-binding | 4.43e-03 | 35 | 53 | 2 | PF00249 | |
| Domain | MYB_LIKE | 5.20e-03 | 38 | 53 | 2 | PS50090 | |
| Domain | - | 8.44e-03 | 283 | 53 | 4 | 1.10.10.60 | |
| Domain | SANT | 8.87e-03 | 50 | 53 | 2 | SM00717 | |
| Domain | SANT/Myb | 9.57e-03 | 52 | 53 | 2 | IPR001005 | |
| Domain | p53-like_TF_DNA-bd | 9.93e-03 | 53 | 53 | 2 | IPR008967 | |
| Pathway | WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K | 2.06e-11 | 99 | 45 | 9 | M46448 |
| Pubmed | TBC1D3, a hominoid oncoprotein, is encoded by a cluster of paralogues located on chromosome 17q12. | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 5.31e-32 | 11 | 55 | 11 | 16863688 |
| Pubmed | DNA sequence of human chromosome 17 and analysis of rearrangement in the human lineage. | 2.76e-11 | 74 | 55 | 7 | 16625196 | |
| Pubmed | 1.50e-08 | 4 | 55 | 3 | 8406013 | ||
| Pubmed | PRC17, a novel oncogene encoding a Rab GTPase-activating protein, is amplified in prostate cancer. | 1.50e-08 | 4 | 55 | 3 | 12359748 | |
| Pubmed | 3.73e-08 | 5 | 55 | 3 | 12604796 | ||
| Pubmed | 3.73e-08 | 5 | 55 | 3 | 8471161 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 1.34e-06 | 351 | 55 | 7 | 38297188 | |
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 36215227 | ||
| Pubmed | 2.46e-06 | 2 | 55 | 2 | 18640248 | ||
| Pubmed | NUT carcinoma of the parotid gland: report of two cases, one with a rare ZNF532-NUTM1 fusion. | 2.46e-06 | 2 | 55 | 2 | 35064291 | |
| Pubmed | Diversity of human copy number variation and multicopy genes. | 7.36e-06 | 3 | 55 | 2 | 21030649 | |
| Pubmed | Overcoming neurite-inhibitory chondroitin sulfate proteoglycans in the astrocyte matrix. | 1.47e-05 | 4 | 55 | 2 | 23554135 | |
| Pubmed | 1.47e-05 | 4 | 55 | 2 | 11604513 | ||
| Pubmed | 1.47e-05 | 4 | 55 | 2 | 19633291 | ||
| Pubmed | 3.67e-05 | 6 | 55 | 2 | 21095589 | ||
| Pubmed | 3.67e-05 | 6 | 55 | 2 | 8810278 | ||
| Pubmed | 4.43e-05 | 246 | 55 | 5 | 15345747 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 5.99e-05 | 430 | 55 | 6 | 35044719 | |
| Pubmed | 6.65e-05 | 268 | 55 | 5 | 33640491 | ||
| Pubmed | Foxp1 gene expression in projection neurons of the mouse striatum. | 6.83e-05 | 8 | 55 | 2 | 14980377 | |
| Pubmed | 7.19e-05 | 1429 | 55 | 10 | 35140242 | ||
| Pubmed | A revised nomenclature for mammalian acyl-CoA thioesterases/hydrolases. | 8.78e-05 | 9 | 55 | 2 | 16103133 | |
| Pubmed | 1.29e-04 | 963 | 55 | 8 | 28671696 | ||
| Pubmed | Functional selectivity of recombinant mammalian SWI/SNF subunits. | 1.34e-04 | 11 | 55 | 2 | 11018012 | |
| Pubmed | 1.52e-04 | 65 | 55 | 3 | 34431227 | ||
| Pubmed | 1.89e-04 | 13 | 55 | 2 | 17670746 | ||
| Pubmed | Essential role of Rac1 and Rac3 GTPases in neuronal development. | 2.21e-04 | 14 | 55 | 2 | 19126596 | |
| Pubmed | Patterning of the third pharyngeal pouch into thymus/parathyroid by Six and Eya1. | 2.54e-04 | 15 | 55 | 2 | 16530750 | |
| Pubmed | 2.90e-04 | 16 | 55 | 2 | 37522516 | ||
| Pubmed | 3.14e-04 | 83 | 55 | 3 | 28794006 | ||
| Pubmed | 3.36e-04 | 591 | 55 | 6 | 15231748 | ||
| Pubmed | 4.01e-04 | 1139 | 55 | 8 | 36417873 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 4.16e-04 | 398 | 55 | 5 | 35016035 | |
| Pubmed | Fine mapping of collagen-induced arthritis quantitative trait loci in an advanced intercross line. | 4.58e-04 | 20 | 55 | 2 | 17082620 | |
| Pubmed | MOZ regulates the Tbx1 locus, and Moz mutation partially phenocopies DiGeorge syndrome. | 4.58e-04 | 20 | 55 | 2 | 22921202 | |
| Pubmed | 4.61e-04 | 407 | 55 | 5 | 12693553 | ||
| Pubmed | 5.20e-04 | 418 | 55 | 5 | 34709266 | ||
| Pubmed | A census of human transcription factors: function, expression and evolution. | 5.51e-04 | 908 | 55 | 7 | 19274049 | |
| Pubmed | 6.08e-04 | 23 | 55 | 2 | 33602870 | ||
| Pubmed | 6.63e-04 | 24 | 55 | 2 | 16582099 | ||
| Pubmed | SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9. | 7.50e-04 | 258 | 55 | 4 | 37794589 | |
| Pubmed | The COPII cargo adapter SEC24C is essential for neuronal homeostasis. | 7.79e-04 | 26 | 55 | 2 | 29939162 | |
| Pubmed | 8.78e-04 | 118 | 55 | 3 | 30979931 | ||
| Pubmed | 1.02e-03 | 486 | 55 | 5 | 20936779 | ||
| Pubmed | 1.04e-03 | 30 | 55 | 2 | 30480076 | ||
| Pubmed | Single-cell transcriptomic landscapes of the otic neuronal lineage at multiple early embryonic ages. | 1.04e-03 | 30 | 55 | 2 | 35320729 | |
| Pubmed | Microarray analysis of the Df1 mouse model of the 22q11 deletion syndrome. | 1.11e-03 | 31 | 55 | 2 | 15778864 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 1.11e-03 | 1024 | 55 | 7 | 24711643 | |
| Pubmed | GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. | 1.18e-03 | 32 | 55 | 2 | 23535730 | |
| Pubmed | 1.20e-03 | 754 | 55 | 6 | 35906200 | ||
| Pubmed | 1.26e-03 | 33 | 55 | 2 | 18356246 | ||
| Pubmed | 1.33e-03 | 34 | 55 | 2 | 1686571 | ||
| Pubmed | Web-based, participant-driven studies yield novel genetic associations for common traits. | 1.33e-03 | 34 | 55 | 2 | 20585627 | |
| Pubmed | 1.41e-03 | 35 | 55 | 2 | 35858542 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 1.53e-03 | 1082 | 55 | 7 | 38697112 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q12 | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 3.06e-17 | 149 | 55 | 11 | chr17q12 |
| Cytoband | 17q12 | 1.34e-07 | 99 | 55 | 5 | 17q12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q15 | 7.47e-04 | 147 | 55 | 3 | chr15q15 | |
| Cytoband | 15q14 | 1.60e-03 | 49 | 55 | 2 | 15q14 | |
| GeneFamily | Acyl-CoA thioesterases | 1.35e-04 | 10 | 32 | 2 | 41 | |
| GeneFamily | StAR related lipid transfer domain containing | 3.14e-04 | 15 | 32 | 2 | 759 | |
| GeneFamily | T-boxes | 4.56e-04 | 18 | 32 | 2 | 766 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 3.95e-03 | 53 | 32 | 2 | 532 | |
| GeneFamily | RNA binding motif containing | 6.22e-03 | 213 | 32 | 3 | 725 | |
| GeneFamily | SH2 domain containing | 1.37e-02 | 101 | 32 | 2 | 741 | |
| Coexpression | GSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_DN | 3.03e-06 | 199 | 53 | 6 | M8974 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_C_D_DN | 1.96e-05 | 276 | 53 | 6 | M8646 | |
| CoexpressionAtlas | Mesoderm Day 15_vs_Mesoderm Day 30-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 1.33e-12 | 90 | 54 | 9 | PCBC_ratio_MESO-15_vs_MESO-30_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5-reprogram_OSKM-L_vs_Mesoderm Day 5-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | TNIK TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 2.01e-09 | 281 | 54 | 10 | PCBC_ratio_MESO-5_from-OSKM-L_vs_MESO-5_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5-method_mRNA_vs_Mesoderm Day 5-method_NA-Confounder_removed-fold2.0_adjp0.05 | TNIK TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 2.01e-09 | 281 | 54 | 10 | PCBC_ratio_MESO-5_from-mRNA_vs_MESO-5_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Endoderm Differentiated Cells-method_mRNA_vs_Endoderm Differentiated Cells-method_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 3.12e-09 | 213 | 54 | 9 | PCBC_ratio_DE_from-mRNA_vs_DE_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Endoderm Differentiated Cells-reprogram_OSKM-L_vs_Endoderm Differentiated Cells-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 3.12e-09 | 213 | 54 | 9 | PCBC_ratio_DE_from-OSKM-L_vs_DE_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | DE cord blood_vs_DE blastocyst-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 9.51e-09 | 242 | 54 | 9 | PCBC_ratio_DE cord blood_vs_DE blastocyst_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 1.05e-07 | 320 | 54 | 9 | PCBC_ratio_MESO-5_vs_DE_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 15_vs_Mesoderm Day 5-Confounder_removed-fold2.0_adjp0.05 | SEC24D MTMR4 TBC1D3 TBC1D3H TBC1D3L TBC1D3D ACOT11 KIAA1217 TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 1.62e-06 | 1049 | 54 | 13 | PCBC_ratio_MESO-15_vs_MESO-5_cfr-2X-p05 |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D MAP2 KIAA1217 HERC1 TBC1D3G TBC1D3C TBC1D3B ADGRL3 TBC1D3K TBC1D3F | 2.13e-06 | 1075 | 54 | 13 | PCBC_ratio_ECTO_vs_DE_cfr-2X-p05 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | 2.87e-05 | 799 | 54 | 10 | gudmap_developingGonad_e18.5_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | SP1 KIAA1217 SMARCC1 GRIA3 HERC1 TUBGCP4 MGA TNS1 KDM6A CRKL | 3.09e-05 | 806 | 54 | 10 | gudmap_developingGonad_e12.5_epididymis_1000 |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L ZNF608 TBC1D3D MAP2 KIAA1217 TBC1D3G TBC1D3C TBC1D3B ADGRL3 TBC1D3K TBC1D3F | 5.89e-05 | 1466 | 54 | 13 | PCBC_ratio_ECTO_vs_SC_cfr-2X-p05 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | 7.24e-05 | 406 | 54 | 7 | gudmap_developingGonad_e16.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | 8.06e-05 | 413 | 54 | 7 | gudmap_developingGonad_e14.5_ epididymis_500 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#3_top-relative-expression-ranked_500 | 1.15e-04 | 188 | 54 | 5 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_500_k3 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | 1.54e-04 | 790 | 54 | 9 | gudmap_developingGonad_e16.5_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | 1.71e-04 | 801 | 54 | 9 | gudmap_developingGonad_e14.5_ epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#4_top-relative-expression-ranked_500 | 3.33e-04 | 53 | 54 | 3 | gudmap_developingGonad_P2_epididymis_500_k4 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_200 | 5.33e-04 | 147 | 54 | 4 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_200 | |
| CoexpressionAtlas | Mesoderm Day 5_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L ZNF608 TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 5.77e-04 | 1153 | 54 | 10 | PCBC_ratio_MESO-5_vs_SC_cfr-2X-p05 |
| CoexpressionAtlas | Stem Cells, SC.LTSL.BM, CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Bone marrow, avg-1 | 5.82e-04 | 409 | 54 | 6 | GSM476663_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000 | 6.74e-04 | 768 | 54 | 8 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000 | |
| CoexpressionAtlas | Stem Cells, SC.STSL.BM, CD117+ IL7R- CD150- CD48- AA4.1+ CD43+, Bone marrow, avg-3 | 6.94e-04 | 423 | 54 | 6 | GSM399454_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | 7.27e-04 | 777 | 54 | 8 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_k-means-cluster#4_top-relative-expression-ranked_1000 | 8.03e-04 | 164 | 54 | 4 | gudmap_developingGonad_e11.5_testes and mesonephros_k4_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#5_top-relative-expression-ranked_500 | 8.19e-04 | 72 | 54 | 3 | gudmap_developingGonad_e18.5_epididymis_500_k5 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | 8.30e-04 | 793 | 54 | 8 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#3_top-relative-expression-ranked_200 | 8.42e-04 | 17 | 54 | 2 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k3_200 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.43e-09 | 166 | 55 | 7 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.36e-07 | 192 | 55 | 6 | 72881b280a415e65f87a80ca1369cbb0b722a0c4 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.36e-06 | 173 | 55 | 5 | 5416b092321c7d9b63f0418c60f2402a138355bf | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L5_RORB_SNHG7|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.90e-05 | 163 | 55 | 4 | 6ed2a71385e85508ed513282c06440add7cc010c | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L5_RORB_SNHG7|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.39e-05 | 167 | 55 | 4 | 5d89f5bcd0aaa772c1d09c2cc46fbfe0a90f9f12 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_ETV4|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.64e-05 | 169 | 55 | 4 | 716e9d4c5fb99c56b76afaa5ed90bfa859fde802 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_KRT17|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.77e-05 | 170 | 55 | 4 | 84d49a1f2989d98bd0acf9ec2d59f1042fc0f55b | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|356C / Donor, Lineage, Cell class and subclass (all cells) | 6.75e-05 | 177 | 55 | 4 | 7617270f49cd6b7ba66db72d20560cee985012b2 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|356C / Donor, Lineage, Cell class and subclass (all cells) | 6.75e-05 | 177 | 55 | 4 | 8220cc2fc0ee8764a67a3be51d75248be2453040 | |
| ToppCell | COVID-19-kidney-vSMC/Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.05e-05 | 179 | 55 | 4 | 111b1084f73306bdeffaaf240e7dbb4f5bf33de1 | |
| ToppCell | droplet-Heart-nan-3m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.21e-05 | 180 | 55 | 4 | da723df348d7b8449bb1124f23fe6fa706412adb | |
| ToppCell | droplet-Heart-nan-3m-Neuronal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.21e-05 | 180 | 55 | 4 | 5b146a94708b3c3610542a4d0925f3f7a2b19185 | |
| ToppCell | droplet-Heart-nan-3m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.21e-05 | 180 | 55 | 4 | 50758b1e7be2e43f83c10ab106900c067e61f5f7 | |
| ToppCell | RA-07._Pericyte|RA / Chamber and Cluster_Paper | 7.36e-05 | 181 | 55 | 4 | 8dfb42d096db6c2df9b41303a7199d134d4bff07 | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D175|Adult / Lineage, Cell type, age group and donor | 7.52e-05 | 182 | 55 | 4 | 8b4a07ebd7a133a33ef333cfa29d12c4f3d4d9ac | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.01e-05 | 185 | 55 | 4 | 9f19f04fc4d97dfc2dd78cde77b515f1cb5d51ec | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.35e-05 | 187 | 55 | 4 | 13731298bc562ec29582f5da1b4c97261284f6f1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.52e-05 | 188 | 55 | 4 | b2d68a32314e9b099ed74d974079ad96359d1ae3 | |
| ToppCell | Control-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | 8.52e-05 | 188 | 55 | 4 | 88b3415e33db81726dd29c1f50c886e057af50a0 | |
| ToppCell | cellseq2-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.70e-05 | 189 | 55 | 4 | bccb3481ffed597c845fe860da658505316105b5 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.88e-05 | 190 | 55 | 4 | 474cbbab8f3b0a6881fa6c92edb78e43999f9ab0 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.88e-05 | 190 | 55 | 4 | 10125091ad648163777b02e9f0d5e8d7f17d44a5 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.06e-05 | 191 | 55 | 4 | 1cb02007adb344f17ef73d58890f91298c7cf5a1 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.06e-05 | 191 | 55 | 4 | 7b0d42a877540dbb346a76a62403e0d5d3e07fa6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.06e-05 | 191 | 55 | 4 | cd854b9c426924fdc84bf7f411f6dea447143e79 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.25e-05 | 192 | 55 | 4 | 24e2f15f5767a97eb3b389922bcfd7b13805e1ce | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Mesenchymal-Smooth_muscle|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 9.43e-05 | 193 | 55 | 4 | 9104b572d9c3c99080e4b7455993fbb944bf117d | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.82e-05 | 195 | 55 | 4 | b072fdc2131173f562e55dd78226eaf2c57d3690 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.00e-04 | 196 | 55 | 4 | 5146976881d79642ebe5dcbcf89e0252713a9ef2 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.00e-04 | 196 | 55 | 4 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.00e-04 | 196 | 55 | 4 | ebac1d6af7a5732707d82d01285c086b19d8ae62 | |
| ToppCell | 11.5-Airway-Mesenchymal|Airway / Age, Tissue, Lineage and Cell class | 1.04e-04 | 198 | 55 | 4 | fe08709d043d927988b1bb262c766b0b572fc927 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.04e-04 | 198 | 55 | 4 | c12e7511628db819a52959bb68580e27c00c2e41 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.04e-04 | 198 | 55 | 4 | 17dc055e2a289496d9c5cdbf3297bdf906dc6d22 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Myofibroblastic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.06e-04 | 199 | 55 | 4 | 9a08c25bb4851ad4ac9db8916422280f71378c2c | |
| ToppCell | Tracheal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.06e-04 | 199 | 55 | 4 | 8ff0fdcbe9661b013913731ec8b53d84836ca865 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.06e-04 | 199 | 55 | 4 | 2ed10c5e15c9d5ed0a8bea580842348d5698a07b | |
| ToppCell | Neuronal-Excitatory-eB(RORB)-FOLH1B--|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.08e-04 | 200 | 55 | 4 | bdda59ffa0496256dd7a5937e88baac5c2a656c3 | |
| ToppCell | Neuronal-Excitatory-eB(RORB)-FOLH1B|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.08e-04 | 200 | 55 | 4 | dff0be30309b6f5f8757b0378ef05ce97f75dbe8 | |
| ToppCell | Neuronal-Excitatory-eB(RORB)-FOLH1B---L4-5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.08e-04 | 200 | 55 | 4 | c3474e8a03ec4869fd3636a5559d36dd9c5fd414 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.08e-04 | 200 | 55 | 4 | 4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.08e-04 | 200 | 55 | 4 | f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.08e-04 | 200 | 55 | 4 | cc3409518f8b436ea92deb955e81114b3f410ff7 | |
| ToppCell | Neuronal-Excitatory-eB(RORB)-FOLH1B-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.08e-04 | 200 | 55 | 4 | 5c0c09e7b84fed053b299848bdff63ab842a445c | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.08e-04 | 200 | 55 | 4 | 310cd53db1c137f6af74e6ae682221d7ac27310c | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.08e-04 | 200 | 55 | 4 | c24a3099e3d96d8b72f6d05286bb355d661a0377 | |
| ToppCell | Macroglial-Polydendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.08e-04 | 200 | 55 | 4 | 961858738ce35db8760c8c2e136f8369bc444ccf | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Papillary_Squamous_Cell_Carcinoma-5|TCGA-Lung / Sample_Type by Project: Shred V9 | 2.97e-04 | 105 | 55 | 3 | ae80ad7e7cd0b42ae7775d45568407cb6403f8e5 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Neuronal-Intermediate|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 3.31e-04 | 109 | 55 | 3 | 48f675d36fece070410eb9cfe64805f4629e290f | |
| ToppCell | Lymphoid-Lymphoid-NK_cells|Lymphoid / shred on cell class and cell subclass (v4) | 8.07e-04 | 148 | 55 | 3 | d51a4b654a88d58dcdf29c2bc362c0cc1c40723a | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cyth3_(Cyth3)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 8.89e-04 | 153 | 55 | 3 | 88ca2d2c2ab19fbee13e18951b993ee05dd30f67 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cyth3_(Cyth3)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 8.89e-04 | 153 | 55 | 3 | 553dff9688a1996d8f4ba16e60c683593d781389 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.23e-04 | 155 | 55 | 3 | c58a5fb8d853f12204e961d633e83452eb12a659 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.23e-04 | 155 | 55 | 3 | 9cb8c42c2e451b2d4dcd7154a4b1bfd21bbb7ea8 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.23e-04 | 155 | 55 | 3 | 77fdae85d36efb776db977eb424b32487ef222e4 | |
| ToppCell | critical-Epithelial-Basal|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 9.23e-04 | 155 | 55 | 3 | cb6fbd36aa1fab29a1667ee13441bddc3d28846f | |
| ToppCell | 368C-Endothelial_cells-Endothelial-E-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 9.40e-04 | 156 | 55 | 3 | 1d681fa17e62815f5d5f90c86be3c248b38e011b | |
| ToppCell | 368C-Endothelial_cells-Endothelial-E|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 9.40e-04 | 156 | 55 | 3 | 4877aabf647238c0279e497345b6a6d5ee07ef9c | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 9.57e-04 | 157 | 55 | 3 | 4183dbed6b31ebe13ef33eb19ba6d0fb4f625953 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.57e-04 | 157 | 55 | 3 | f147e24f2ece82e1c54750868954d09b3c461804 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_TBC1D26|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.75e-04 | 158 | 55 | 3 | 3d6295fe25e3b1fb4b6e83704c5bdbf86dc639b3 | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D231|Adult / Lineage, Cell type, age group and donor | 9.75e-04 | 158 | 55 | 3 | 8d64c0c9de910a3f4658778642d183c8b9b6f6a2 | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 9.75e-04 | 158 | 55 | 3 | de65af8d3b8514b17978155f31975e2347b75251 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.75e-04 | 158 | 55 | 3 | e5636c0b608d68bd426a2b446ac508e4512e86a4 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-Trm_Th1/Th17|bone_marrow / Manually curated celltypes from each tissue | 1.07e-03 | 163 | 55 | 3 | 4d1fd0b1246833723b938eca0cb246e937380e12 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-epithelial_progenitor_cell-Distal_progenitor|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.09e-03 | 164 | 55 | 3 | d6f71d804bb65301c02ea4e6673e20688b5fcd5b | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast-MatrixFB-A|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.09e-03 | 164 | 55 | 3 | 519ab4fe885dfe4c50846f346a062acc2cb44299 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_KRT17|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.10e-03 | 165 | 55 | 3 | fee7f2f8d0e25c0d067adc73f8913721bd709a3e | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.10e-03 | 165 | 55 | 3 | 8a82e20c9b1156bb4bbc16f7785abb04458d671b | |
| ToppCell | LV-16._Neuronal|World / Chamber and Cluster_Paper | 1.10e-03 | 165 | 55 | 3 | 6ed52cb756d21addf46c7f6c457458b01339fe04 | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Alveolar_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.12e-03 | 166 | 55 | 3 | 65dafed953b01a9830b54309af75c7a561e88336 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_KRT17|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.12e-03 | 166 | 55 | 3 | 739dfbe927f409821ff23aca6e47ebe78f57e859 | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-03 | 166 | 55 | 3 | 9adceb746e67e955fd8b3e0984f4eed44b64a270 | |
| ToppCell | facs-Aorta-Heart-3m-Endothelial-endocardial_endothelial_cells|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-03 | 167 | 55 | 3 | a4a795751644b22af616335379e64ae95175180c | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_B_(ET)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.16e-03 | 168 | 55 | 3 | 8e9046b661642293eee640ead91d43db9d8daae0 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.16e-03 | 168 | 55 | 3 | 217770a94ace446cdfc7687b459dece707576e76 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.16e-03 | 168 | 55 | 3 | 27cdf5cfa1d906868cfd60fdfab3cd51f3b3602f | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_B_(ET)-Glut_ET_L5_FEZF2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.16e-03 | 168 | 55 | 3 | c7d66e5d9311ceaab3f144f1516b49b8812976b8 | |
| ToppCell | COVID-19-Heart-Neuronal|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.16e-03 | 168 | 55 | 3 | 88c2c574f428c2502b5fe099bd73b0758f668ef6 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L3-5_THEMIS_UBE2F|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.16e-03 | 168 | 55 | 3 | bfa1491e8d433933003778b274710d3a16d973cb | |
| ToppCell | P28-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.16e-03 | 168 | 55 | 3 | 8c8dbdbc7053f34e4ca0c5067af502fbea109fc1 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.18e-03 | 169 | 55 | 3 | 0c341f91dc21aaf92bead18d59684d11510502ce | |
| ToppCell | droplet-Lung-nan-3m-Lymphocytic-Natural_Killer_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-03 | 169 | 55 | 3 | 7ec2b6b55f51edc0084db73eaf42ae319a24f77a | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.18e-03 | 169 | 55 | 3 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | droplet-Lung-nan-3m-Lymphocytic-mature_NK_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-03 | 169 | 55 | 3 | 9df20ce0c2661eb4b3ce4c0b857e38485fabd46d | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.20e-03 | 170 | 55 | 3 | 417b77c12a7982b1ce4b4bc57f30335d261220f5 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-03 | 171 | 55 | 3 | 6a0fafb8fd9fc7671618eeb2bf528ce8ce86b794 | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-03 | 171 | 55 | 3 | b54d9d6b03c9c6f28a71cf2ed2bfa9a335bba949 | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-03 | 171 | 55 | 3 | 9d825a2e799421af4f2cf4f4dc8e239b5d00476d | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.22e-03 | 171 | 55 | 3 | a5634b76476b8b2488a706bbab5141f7bd94631f | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-plasmacytoid_dendritic_cell-plasmacytoid_dendritic|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.22e-03 | 171 | 55 | 3 | 2dfed6e9ac89adb2501a1a5e1ca895f49190562d | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.22e-03 | 171 | 55 | 3 | f648789e6aefe508bb748401bf9b3cd830fb0ddf | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-03 | 171 | 55 | 3 | e02b5831768dbb1b68998b672e55c9680ab0cc86 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_LCN15|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.22e-03 | 171 | 55 | 3 | 9e00c8191ca9d52151a49baf39f8581cb176fb76 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-plasmacytoid_dendritic_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.22e-03 | 171 | 55 | 3 | 2aaae0229c3a13d0275a03a3d576db650c2bf2c0 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_LCN15|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.22e-03 | 171 | 55 | 3 | 6a489a75eeab2a2d48d604682e93599c20a945fe | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-03 | 172 | 55 | 3 | 7fb31ccbcd0204c3612986a6bc20d57ed6825e9c | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.24e-03 | 172 | 55 | 3 | 41ddfb316429efef5f3fa0b0621ced383d9206f0 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.24e-03 | 172 | 55 | 3 | cecfe5cf20f317ea01b4604789e07a14481c4cd6 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_LCN15|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.24e-03 | 172 | 55 | 3 | 92e76cbf4807704790f42cf2507e92f85cd3bc92 | |
| Drug | Pramoxine hydrochloride [637-58-1]; Down 200; 12.2uM; PC3; HT_HG-U133A | 2.95e-06 | 191 | 48 | 6 | 3811_DN | |
| Disease | Child Behaviour Checklist assessment | 3.43e-04 | 18 | 45 | 2 | EFO_0005661 | |
| Disease | DiGeorge syndrome (implicated_via_orthology) | 3.83e-04 | 19 | 45 | 2 | DOID:11198 (implicated_via_orthology) | |
| Disease | CCL4 measurement | 4.25e-04 | 20 | 45 | 2 | EFO_0004751 | |
| Disease | resting heart rate, chronic obstructive pulmonary disease | 9.63e-04 | 30 | 45 | 2 | EFO_0000341, EFO_0004351 | |
| Disease | renal cell carcinoma (is_marker_for) | 9.90e-04 | 128 | 45 | 3 | DOID:4450 (is_marker_for) | |
| Disease | macrophage inflammatory protein 1b measurement | 1.18e-03 | 136 | 45 | 3 | EFO_0008219 | |
| Disease | glycine measurement | 1.20e-03 | 137 | 45 | 3 | EFO_0009767 | |
| Disease | Otitis media | 1.63e-03 | 39 | 45 | 2 | EFO_0004992 | |
| Disease | hypospadias | 1.63e-03 | 39 | 45 | 2 | EFO_0004209 | |
| Disease | FEV/FEC ratio | 2.42e-03 | 1228 | 45 | 7 | EFO_0004713 | |
| Disease | overall survival, pancreatic carcinoma | 2.56e-03 | 49 | 45 | 2 | EFO_0000638, EFO_0002618 | |
| Disease | uterine fibroid | 3.48e-03 | 199 | 45 | 3 | EFO_0000731 | |
| Disease | ovarian cancer (is_marker_for) | 4.86e-03 | 68 | 45 | 2 | DOID:2394 (is_marker_for) | |
| Disease | obesity | 5.93e-03 | 241 | 45 | 3 | EFO_0001073 | |
| Disease | response to angiotensin-converting enzyme inhibitor | 6.34e-03 | 78 | 45 | 2 | EFO_0005325 | |
| Disease | melanoma | 6.42e-03 | 248 | 45 | 3 | C0025202 | |
| Disease | mean arterial pressure | 6.96e-03 | 499 | 45 | 4 | EFO_0006340 | |
| Disease | Unipolar Depression | 7.23e-03 | 259 | 45 | 3 | C0041696 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HGNAGNIGHRLPNAL | 121 | Q7L211 | |
| RFGSHVNQGPLHLGG | 346 | Q7Z2Y8 | |
| FGPLDSRSGQAHHGQ | 391 | Q9HAR2 | |
| VLPPHANHQGNTFGG | 226 | Q8WXI4 | |
| PPHANHHGNTFGGQI | 191 | Q8WYK0 | |
| NLLHNNGHNGYPNGT | 6 | O75534 | |
| AHAFQPGQGIGGDAH | 181 | P22894 | |
| INQDAGFHTNGTGHG | 126 | Q8IXT5 | |
| FPNQHIAGQAGPGHS | 491 | Q9HCJ3 | |
| TPLASAGFGHGGQNA | 271 | A6NCS4 | |
| AGFGHGGQNATPQGH | 276 | A6NCS4 | |
| IKNGHTGLSNGNGIH | 96 | Q9P1T7 | |
| AHGLQGNGSYGTPHI | 346 | O43365 | |
| GNGHFQGHLLLPGEQ | 2266 | Q8IWI9 | |
| GSNSEGQLGLGHTNH | 4316 | Q15751 | |
| QGLHKGQSSHSAGPN | 641 | O15550 | |
| GLLGHSHGGFPNTIS | 21 | P42263 | |
| HNGNSDPRGFGHIGI | 116 | Q04760 | |
| GPGLGLGVASQHFSH | 106 | Q7L5A3 | |
| GLGSIHNSQQGLPHY | 186 | Q9UBC0 | |
| RQSLGHGQHGSGSGQ | 991 | Q86YZ3 | |
| RQSLGHGQHGSGSGQ | 1461 | Q86YZ3 | |
| RQSLGHGQHGSGSGQ | 1931 | Q86YZ3 | |
| RQSLGHGQHGSGSGQ | 2401 | Q86YZ3 | |
| GSGNHNPAKHQLQNG | 201 | Q14678 | |
| NHLAGQNHGFPLGST | 56 | Q6ZN66 | |
| HHPSQQGQGGLHGIY | 71 | Q9UGJ1 | |
| PHGKHGNRNSNSYGI | 186 | P46109 | |
| FGGGNHQHIGKPSTI | 211 | P62917 | |
| SHSNGHCTGPGGKNQ | 966 | Q9NYA4 | |
| GGGSFLQRHHPGAQA | 36 | Q5BKU9 | |
| NQVSLHQDGHLGGAG | 591 | Q86Y26 | |
| GRQGIPGQQGIQGHH | 716 | Q96P44 | |
| PGQFHGLHDGSHASQ | 781 | Q53TQ3 | |
| LTQNPFGNLGHTTGG | 81 | O43897 | |
| GKGHHLSFSPQSQNG | 1871 | Q5T5P2 | |
| NAPGDHGAQLGLHGA | 556 | P08047 | |
| LQGFHSPNGGTVQGL | 221 | B9A6J9 | |
| NPQQAHQHSGGPGLA | 966 | Q92922 | |
| PHQFGQNGAHATGHP | 66 | O94855 | |
| GLHQGGHPEAQSALG | 2641 | Q9NRC6 | |
| LQGFHSPNGGTVQGL | 221 | A6NDS4 | |
| LQGFHSPNGGTVQGL | 221 | P0C7X1 | |
| GHNPTGNGLHNGFLT | 81 | Q9HCE3 | |
| GHSDSNGFAGHINLP | 916 | Q9UKE5 | |
| HLFLNGTGGQTHLSP | 381 | P17643 | |
| LQGFHSPNGGTVQGL | 221 | A6NER0 | |
| SSHLHGQQFFGPLGA | 471 | Q13207 | |
| SLGRHPGAHQGNLAS | 1271 | Q9HBL0 | |
| PGAHQGNLASGLHSN | 1276 | Q9HBL0 | |
| LQGFHSPNGGTVQGL | 221 | A0A087X179 | |
| FAQGGHSQGHVVPGG | 906 | Q14151 | |
| GSLDNAHHVPGGGNV | 1741 | P11137 | |
| HQNGSGSQAPSGGHL | 221 | Q9ULD9 | |
| LQGFHSPNGGTVQGL | 221 | A0A087WVF3 | |
| LQGFHSPNGGTVQGL | 221 | Q6DHY5 | |
| LQGFHSPNGGTVQGL | 221 | Q8IZP1 | |
| LQGFHSPNGGTVQGL | 221 | A0A087X1G2 | |
| LQGFHSPNGGTVQGL | 221 | A0A087WXS9 | |
| LQGFHSPNGGTVQGL | 221 | Q6IPX1 | |
| GSHAGPGNHVQLRGN | 86 | Q96PN7 |